SD

Sunil Dhanraj Ostwal

Director Director DIN 02741956
DIN 02741956 First appointment Oct 2009 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2009
Shareholding value Locked Premium profile

About Sunil Dhanraj Ostwal

Sunil Dhanraj Ostwal has 16 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 02741956
Primary Designation Director
First Appointment 14 Oct 2009
Oldest Company Age 16 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Bellis Pharmaceuticals Limited U24232KA2009PLC051193
Director 14 Oct 2009 2009 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bellis Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Sunil Dhanraj Ostwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Dhanraj Ostwal

Sunil Dhanraj Ostwal has 16 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Sunil Dhanraj Ostwal is associated with 0 companies as Director.

Sunil Dhanraj Ostwal has expertise in General Business.

Sunil Dhanraj Ostwal has 16 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available